The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Alogliptin is a selective, orally-bioavailable inhibitor of enzymatic activity of dipeptidyl peptidase-4 (DPP-4). Chemically, alogliptin is prepared as a benzoate salt and exists predominantly as the R-enantiomer (>99%).
The global Alogliptin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Alogliptin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Alogliptin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Alogliptin include Takeda, Perrigo, Hikma Pharmaceuticals, Furiex Pharma, Allergan and Sanofi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Alogliptin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alogliptin.
Report Scope
The Alogliptin market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alogliptin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alogliptin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Perrigo
Hikma Pharmaceuticals
Furiex Pharma
Allergan
Sanofi
Segment by Type
6.25 Mg Tablet
25 Mg Tablet
12.5 Mg Tablet
15 Mg Tablet
Other
Segment by Application
Diabetes
Hypercholesterolemia
Obesity
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alogliptin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alogliptin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Alogliptin is a selective, orally-bioavailable inhibitor of enzymatic activity of dipeptidyl peptidase-4 (DPP-4). Chemically, alogliptin is prepared as a benzoate salt and exists predominantly as the R-enantiomer (>99%).
The global Alogliptin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Alogliptin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Alogliptin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Alogliptin include Takeda, Perrigo, Hikma Pharmaceuticals, Furiex Pharma, Allergan and Sanofi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Alogliptin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alogliptin.
Report Scope
The Alogliptin market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alogliptin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alogliptin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Perrigo
Hikma Pharmaceuticals
Furiex Pharma
Allergan
Sanofi
Segment by Type
6.25 Mg Tablet
25 Mg Tablet
12.5 Mg Tablet
15 Mg Tablet
Other
Segment by Application
Diabetes
Hypercholesterolemia
Obesity
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alogliptin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alogliptin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Alogliptin Market Overview
1.1 Product Overview and Scope of Alogliptin
1.2 Alogliptin Segment by Type
1.2.1 Global Alogliptin Market Value Comparison by Type (2024-2030)
1.2.2 6.25 Mg Tablet
1.2.3 25 Mg Tablet
1.2.4 12.5 Mg Tablet
1.2.5 15 Mg Tablet
1.2.6 Other
1.3 Alogliptin Segment by Application
1.3.1 Global Alogliptin Market Value by Application: (2024-2030)
1.3.2 Diabetes
1.3.3 Hypercholesterolemia
1.3.4 Obesity
1.3.5 Other
1.4 Global Alogliptin Market Size Estimates and Forecasts
1.4.1 Global Alogliptin Revenue 2019-2030
1.4.2 Global Alogliptin Sales 2019-2030
1.4.3 Global Alogliptin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Alogliptin Market Competition by Manufacturers
2.1 Global Alogliptin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Alogliptin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Alogliptin Average Price by Manufacturers (2019-2024)
2.4 Global Alogliptin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alogliptin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alogliptin, Product Type & Application
2.7 Alogliptin Market Competitive Situation and Trends
2.7.1 Alogliptin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alogliptin Players Market Share by Revenue
2.7.3 Global Alogliptin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alogliptin Retrospective Market Scenario by Region
3.1 Global Alogliptin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Alogliptin Global Alogliptin Sales by Region: 2019-2030
3.2.1 Global Alogliptin Sales by Region: 2019-2024
3.2.2 Global Alogliptin Sales by Region: 2025-2030
3.3 Global Alogliptin Global Alogliptin Revenue by Region: 2019-2030
3.3.1 Global Alogliptin Revenue by Region: 2019-2024
3.3.2 Global Alogliptin Revenue by Region: 2025-2030
3.4 North America Alogliptin Market Facts & Figures by Country
3.4.1 North America Alogliptin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Alogliptin Sales by Country (2019-2030)
3.4.3 North America Alogliptin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alogliptin Market Facts & Figures by Country
3.5.1 Europe Alogliptin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Alogliptin Sales by Country (2019-2030)
3.5.3 Europe Alogliptin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alogliptin Market Facts & Figures by Country
3.6.1 Asia Pacific Alogliptin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Alogliptin Sales by Country (2019-2030)
3.6.3 Asia Pacific Alogliptin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Alogliptin Market Facts & Figures by Country
3.7.1 Latin America Alogliptin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Alogliptin Sales by Country (2019-2030)
3.7.3 Latin America Alogliptin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alogliptin Market Facts & Figures by Country
3.8.1 Middle East and Africa Alogliptin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Alogliptin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Alogliptin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alogliptin Sales by Type (2019-2030)
4.1.1 Global Alogliptin Sales by Type (2019-2024)
4.1.2 Global Alogliptin Sales by Type (2025-2030)
4.1.3 Global Alogliptin Sales Market Share by Type (2019-2030)
4.2 Global Alogliptin Revenue by Type (2019-2030)
4.2.1 Global Alogliptin Revenue by Type (2019-2024)
4.2.2 Global Alogliptin Revenue by Type (2025-2030)
4.2.3 Global Alogliptin Revenue Market Share by Type (2019-2030)
4.3 Global Alogliptin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Alogliptin Sales by Application (2019-2030)
5.1.1 Global Alogliptin Sales by Application (2019-2024)
5.1.2 Global Alogliptin Sales by Application (2025-2030)
5.1.3 Global Alogliptin Sales Market Share by Application (2019-2030)
5.2 Global Alogliptin Revenue by Application (2019-2030)
5.2.1 Global Alogliptin Revenue by Application (2019-2024)
5.2.2 Global Alogliptin Revenue by Application (2025-2030)
5.2.3 Global Alogliptin Revenue Market Share by Application (2019-2030)
5.3 Global Alogliptin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Alogliptin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Alogliptin Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Perrigo
6.2.1 Perrigo Corporation Information
6.2.2 Perrigo Description and Business Overview
6.2.3 Perrigo Alogliptin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Perrigo Alogliptin Product Portfolio
6.2.5 Perrigo Recent Developments/Updates
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Corporation Information
6.3.2 Hikma Pharmaceuticals Description and Business Overview
6.3.3 Hikma Pharmaceuticals Alogliptin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hikma Pharmaceuticals Alogliptin Product Portfolio
6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
6.4 Furiex Pharma
6.4.1 Furiex Pharma Corporation Information
6.4.2 Furiex Pharma Description and Business Overview
6.4.3 Furiex Pharma Alogliptin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Furiex Pharma Alogliptin Product Portfolio
6.4.5 Furiex Pharma Recent Developments/Updates
6.5 Allergan
6.5.1 Allergan Corporation Information
6.5.2 Allergan Description and Business Overview
6.5.3 Allergan Alogliptin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Allergan Alogliptin Product Portfolio
6.5.5 Allergan Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Alogliptin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Alogliptin Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alogliptin Industry Chain Analysis
7.2 Alogliptin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alogliptin Production Mode & Process
7.4 Alogliptin Sales and Marketing
7.4.1 Alogliptin Sales Channels
7.4.2 Alogliptin Distributors
7.5 Alogliptin Customers
8 Alogliptin Market Dynamics
8.1 Alogliptin Industry Trends
8.2 Alogliptin Market Drivers
8.3 Alogliptin Market Challenges
8.4 Alogliptin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Alogliptin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Alogliptin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Alogliptin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Alogliptin Sales (M Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Alogliptin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Alogliptin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Alogliptin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Alogliptin Average Price (US$/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Alogliptin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Alogliptin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Alogliptin, Product Type & Application
Table 12. Global Key Manufacturers of Alogliptin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alogliptin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alogliptin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alogliptin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Alogliptin Sales by Region (2019-2024) & (M Pcs)
Table 18. Global Alogliptin Sales Market Share by Region (2019-2024)
Table 19. Global Alogliptin Sales by Region (2025-2030) & (M Pcs)
Table 20. Global Alogliptin Sales Market Share by Region (2025-2030)
Table 21. Global Alogliptin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Alogliptin Revenue Market Share by Region (2019-2024)
Table 23. Global Alogliptin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Alogliptin Revenue Market Share by Region (2025-2030)
Table 25. North America Alogliptin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Alogliptin Sales by Country (2019-2024) & (M Pcs)
Table 27. North America Alogliptin Sales by Country (2025-2030) & (M Pcs)
Table 28. North America Alogliptin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Alogliptin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Alogliptin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Alogliptin Sales by Country (2019-2024) & (M Pcs)
Table 32. Europe Alogliptin Sales by Country (2025-2030) & (M Pcs)
Table 33. Europe Alogliptin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Alogliptin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Alogliptin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Alogliptin Sales by Region (2019-2024) & (M Pcs)
Table 37. Asia Pacific Alogliptin Sales by Region (2025-2030) & (M Pcs)
Table 38. Asia Pacific Alogliptin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Alogliptin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Alogliptin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Alogliptin Sales by Country (2019-2024) & (M Pcs)
Table 42. Latin America Alogliptin Sales by Country (2025-2030) & (M Pcs)
Table 43. Latin America Alogliptin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Alogliptin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Alogliptin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Alogliptin Sales by Country (2019-2024) & (M Pcs)
Table 47. Middle East & Africa Alogliptin Sales by Country (2025-2030) & (M Pcs)
Table 48. Middle East & Africa Alogliptin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Alogliptin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Alogliptin Sales (M Pcs) by Type (2019-2024)
Table 51. Global Alogliptin Sales (M Pcs) by Type (2025-2030)
Table 52. Global Alogliptin Sales Market Share by Type (2019-2024)
Table 53. Global Alogliptin Sales Market Share by Type (2025-2030)
Table 54. Global Alogliptin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Alogliptin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Alogliptin Revenue Market Share by Type (2019-2024)
Table 57. Global Alogliptin Revenue Market Share by Type (2025-2030)
Table 58. Global Alogliptin Price (US$/Pcs) by Type (2019-2024)
Table 59. Global Alogliptin Price (US$/Pcs) by Type (2025-2030)
Table 60. Global Alogliptin Sales (M Pcs) by Application (2019-2024)
Table 61. Global Alogliptin Sales (M Pcs) by Application (2025-2030)
Table 62. Global Alogliptin Sales Market Share by Application (2019-2024)
Table 63. Global Alogliptin Sales Market Share by Application (2025-2030)
Table 64. Global Alogliptin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Alogliptin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Alogliptin Revenue Market Share by Application (2019-2024)
Table 67. Global Alogliptin Revenue Market Share by Application (2025-2030)
Table 68. Global Alogliptin Price (US$/Pcs) by Application (2019-2024)
Table 69. Global Alogliptin Price (US$/Pcs) by Application (2025-2030)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Alogliptin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 73. Takeda Alogliptin Product
Table 74. Takeda Recent Developments/Updates
Table 75. Perrigo Corporation Information
Table 76. Perrigo Description and Business Overview
Table 77. Perrigo Alogliptin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 78. Perrigo Alogliptin Product
Table 79. Perrigo Recent Developments/Updates
Table 80. Hikma Pharmaceuticals Corporation Information
Table 81. Hikma Pharmaceuticals Description and Business Overview
Table 82. Hikma Pharmaceuticals Alogliptin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 83. Hikma Pharmaceuticals Alogliptin Product
Table 84. Hikma Pharmaceuticals Recent Developments/Updates
Table 85. Furiex Pharma Corporation Information
Table 86. Furiex Pharma Description and Business Overview
Table 87. Furiex Pharma Alogliptin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 88. Furiex Pharma Alogliptin Product
Table 89. Furiex Pharma Recent Developments/Updates
Table 90. Allergan Corporation Information
Table 91. Allergan Description and Business Overview
Table 92. Allergan Alogliptin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 93. Allergan Alogliptin Product
Table 94. Allergan Recent Developments/Updates
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Alogliptin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 98. Sanofi Alogliptin Product
Table 99. Sanofi Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Alogliptin Distributors List
Table 103. Alogliptin Customers List
Table 104. Alogliptin Market Trends
Table 105. Alogliptin Market Drivers
Table 106. Alogliptin Market Challenges
Table 107. Alogliptin Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Alogliptin
Figure 2. Global Alogliptin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Alogliptin Market Share by Type in 2023 & 2030
Figure 4. 6.25 Mg Tablet Product Picture
Figure 5. 25 Mg Tablet Product Picture
Figure 6. 12.5 Mg Tablet Product Picture
Figure 7. 15 Mg Tablet Product Picture
Figure 8. Other Product Picture
Figure 9. Global Alogliptin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Alogliptin Market Share by Application in 2023 & 2030
Figure 11. Diabetes
Figure 12. Hypercholesterolemia
Figure 13. Obesity
Figure 14. Other
Figure 15. Global Alogliptin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Alogliptin Market Size (2019-2030) & (US$ Million)
Figure 17. Global Alogliptin Sales (2019-2030) & (M Pcs)
Figure 18. Global Alogliptin Average Price (US$/Pcs) & (2019-2030)
Figure 19. Alogliptin Report Years Considered
Figure 20. Alogliptin Sales Share by Manufacturers in 2023
Figure 21. Global Alogliptin Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Alogliptin Players: Market Share by Revenue in 2023
Figure 23. Alogliptin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Alogliptin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Alogliptin Sales Market Share by Country (2019-2030)
Figure 26. North America Alogliptin Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Alogliptin Sales Market Share by Country (2019-2030)
Figure 30. Europe Alogliptin Revenue Market Share by Country (2019-2030)
Figure 31. Germany Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Alogliptin Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Alogliptin Revenue Market Share by Region (2019-2030)
Figure 38. China Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Alogliptin Sales Market Share by Country (2019-2030)
Figure 49. Latin America Alogliptin Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Alogliptin Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Alogliptin Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Alogliptin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Alogliptin by Type (2019-2030)
Figure 59. Global Revenue Market Share of Alogliptin by Type (2019-2030)
Figure 60. Global Alogliptin Price (US$/Pcs) by Type (2019-2030)
Figure 61. Global Sales Market Share of Alogliptin by Application (2019-2030)
Figure 62. Global Revenue Market Share of Alogliptin by Application (2019-2030)
Figure 63. Global Alogliptin Price (US$/Pcs) by Application (2019-2030)
Figure 64. Alogliptin Value Chain
Figure 65. Alogliptin Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
